Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample

American Journal of Transplantation

Volumn 16, Issue 9, 2016, Pages 2684-2694

  VanWagner, L B ^a   Serper, M ^b   Kang, R ^a   Levitsky, J ^a   Hohmann, S ^c,d   Abecassis, M ^a   Skaro, A ^a   Lloyd Jones, D M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c University HealthSystem Consortium ^*  (United States)

^d RUSH UNIVERSITY   (United States)

Author keywords

cardiovascular disease; clinical research practice; comorbidities; complication: medical metabolic; health services and outcomes research; liver transplantation hepatology; Organ Procurement and Transplantation Network (OPTN); risk assessment risk stratification

Indexed keywords

CREATININE;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CLINICAL OUTCOME; COHORT ANALYSIS; FEMALE; HEART ARREST; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; ICD-9; IMMUNOPROPHYLAXIS; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NONALCOHOLIC FATTY LIVER; OBESITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 84984600801     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13779     Document Type: Article

References (49)

1. VanWagner LB, Lapin B, Levitsky J, et al. High early cardiovascular mortality after liver transplantation. Liver Transpl 2014; 20: 1306–1316.
2. Albeldawi M, Aggarwal A, Madhwal S, et al. Cumulative risk of cardiovascular events after orthotopic liver transplantation. Liver Transpl 2012; 18: 370–375.
3. Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002; 73: 901–906.
4. Annual Report of the U.S. Organ Procurement and Transplantation Network (OPTN) and the Scientific Registry of Transplant Recipients (SRTR): Transplant Data 1998–2011. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, 2012.
5. Audet M, Piardi T, Panaro F, et al. Liver transplantation in recipients over 65 yr old: A single center experience. Clin Transplant 2010; 24: 84–90.
6. Zetterman RK, Belle SH, Hoofnagle JH, et al. Age and liver transplantation: A report of the Liver Transplantation Database. Transplantation 1998; 66: 500–506.
7. Wedd JP, Harper AM, Biggins SW. MELD score, allocation, and distribution in the United States. Clin Liv Dis 2013; 2: 148–151.
8. Saab S, Lalezari D, Pruthi P, Alper T, Tong MJ. The impact of obesity on patient survival in liver transplant recipients: A meta-analysis. Liver Int 2015; 35: 164–170.
9. Wong RJ, Cheung R, Perumpail RB, Holt EW, Ahmed A. Diabetes mellitus, and not obesity, is associated with lower survival following liver transplantation. Dig Dis Sci 2015; 60: 1036–1044.
10. VanWagner LB, Lapin B, Skaro AI, Lloyd-Jones DM, Rinella ME. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver Int 2015; 35: 2575–2583.
11. Vanwagner LB, Bhave M, Te HS, Feinglass J, Alvarez L, Rinella ME. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology 2012; 56: 1741–1750.
12. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249–1253.
13. Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015; 148: 547–555.
14. Safadi A, Homsi M, Maskoun W, et al. Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery. Circulation 2009; 120: 1189–1194.
15. Fouad TR, Abdel-Razek WM, Burak KW, Bain VG, Lee SS. Prediction of cardiac complications after liver transplantation. Transplantation 2009; 87: 763–770.
16. Coss E, Watt KD, Pedersen R, Dierkhising R, Heimbach JK, Charlton MR. Predictors of cardiovascular events after liver transplantation: A role for pretransplant serum troponin levels. Liver Transpl 2011; 17: 23–31.
17. Bargehr J, Trejo-Gutierrez JF, Patel T, et al. Preexisting atrial fibrillation and cardiac complications after liver transplantation. Liver Transpl 2015; 21: 314–320.
18. Nicolau-Raducu R, Gitman M, Ganier D, et al. Adverse cardiac events after orthotopic liver transplantation: A cross-sectional study in 389 consecutive patients. Liver Transpl 2015; 21: 13–21.
19. Josefsson A, Fu M, Bjornsson E, Castedal M, Kalaitzakis E. Pre-transplant renal impairment predicts posttransplant cardiac events in patients with liver cirrhosis. Transplantation 2014; 98: 107–114.
20. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64: e1–e76.
21. Salvalaggio PR, Dzebisashvili N, MacLeod KE, et al. The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation. Liver Transpl 2011; 17: 233–242.
22. Raval Z, Harinstein ME, Skaro AI, et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol 2011; 58: 223–231.
23. Rao A, Polanco A, Qiu S, et al. Safety of outpatient laparoscopic cholecystectomy in the elderly: Analysis of 15,248 patients using the NSQIP database. J Am Coll Surg 2013; 217: 1038–1043.
24. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes. Ann Surg 1997; 226: 248–257; discussion 57-60.
25. Salerno MP, Piselli P, Rossi E, et al. Metabolic syndrome and cardiovascular disease in kidney transplantation. Transplant Proc 2011; 43: 1067–1068.
26. Claes K, Bammens B, Evenepoel P, et al. Troponin I is a predictor of acute cardiac events in the immediate postoperative renal transplant period. Transplantation 2010; 89: 341–346.
27. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043–1049.
28. Wiese S, Hove JD, Bendtsen F, Moller S. Cirrhotic cardiomyopathy: Pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2014; 11: 177–186.
29. Rumer KK, Saraswathula A, Melcher ML. Prehabilitation in our most frail surgical patients: Are wearable fitness devices the next frontier? Curr Opin Organ Transplant 2016; 21: 188–193.
30. Piccini JP, Hammill BG, Sinner MF, et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes 2012; 5: 85–93.
31. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002; 113: 359–364.
32. Gaynor JJ, Moon JI, Kato T, et al. A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation. Transplantation 2007; 84: 155–165.
33. Zheng Y, Villamayor AJ, Merritt W, et al. Continuous cerebral blood flow autoregulation monitoring in patients undergoing liver transplantation. Neurocrit Care 2012; 17: 77–84.
34. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53: 372–384.
35. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005–2023.
36. Bonora E, Targher G. Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol 2012; 9: 372–381.
37. Wang X, Li J, Riaz DR, Shi G, Liu C, Dai Y. Outcomes of liver transplantation for nonalcoholic steatohepatitis: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 2014; 12: 394–402.e1.
38. VanWagner LB, Ning H, Lewis CE, et al. Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The Coronary Artery Risk Development in Young Adults Study. Atherosclerosis 2014; 235: 599–605.
39. VanWagner LB, Wilcox JE, Colangelo LA, et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study. Hepatology 2015; 62: 773–783.
40. Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 2008; 49: 608–612.
41. Ekstedt M, Hagstrom H, Nasr P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 2015; 61: 1547–1554.
42. Lazarevic AM, Nakatani S, Neskovic AN, et al. Early changes in left ventricular function in chronic asymptomatic alcoholics: Relation to the duration of heavy drinking. J Am Coll Cardiol 2000; 35: 1599–1606.
43. Piano MR. Alcoholic cardiomyopathy: Incidence, clinical characteristics, and pathophysiology. Chest 2002; 121: 1638–1650.
44. O'Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM. Measuring Diagnoses: ICD Code Accuracy. Health Serv Res 2005; 40: 1620–1639.
45. Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care 2005; 43: 480–485.
46. VanWagner LB, Skaro AI. Program-specific reports: Implications and impact on program behavior. Curr Opin Organ Transplant 2013; 18: 210–215.
47. Abecassis MM, Burke R, Cosimi AB, et al. Transplant center regulations–a mixed blessing? An ASTS Council viewpoint. Am J Transplant 2008; 8: 2496–2502.
48. Mayo NE, Feldman L, Scott S, et al. Impact of preoperative change in physical function on postoperative recovery: Argument supporting prehabilitation for colorectal surgery. Surgery 2011; 150: 505–514.
49. Dunne DF, Jack S, Jones RP, et al. Randomized clinical trial of prehabilitation before planned liver resection. Br J Surg 2016; 103: 504–512.